Oric Pharmaceuticals’ (ORIC) Outperform Rating Reiterated at Wedbush
Wedbush reissued their outperform rating on shares of Oric Pharmaceuticals (NASDAQ:ORIC – Free Report) in a research note published on Monday morning,RTT News reports. Wedbush currently has a $20.00 price target on the stock. ORIC has been the subject of a number of other research reports. Guggenheim reaffirmed a “buy” rating on shares of Oric […]
Wedbush reissued their outperform rating on shares of Oric Pharmaceuticals (NASDAQ:ORIC – Free Report) in a research note published on Monday morning,RTT News reports. Wedbush currently has a $20.00 price target on the stock. ORIC has been the subject of a number of other research reports. Guggenheim reaffirmed a “buy” rating on shares of Oric […]
